Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria

Cellular and Molecular Life Sciences

Volumn 69, Issue 15, 2012, Pages 2583-2592

  Imai, Kenichi ^a,b   Yamada, Kiyoshi ^b   Tamura, Muneaki ^b   Ochiai, Kuniyasu ^b   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Butyric acid; Epigenetics; HDAC; Histone; HIV 1

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE;

ANAEROBIC BACTERIUM; ANAEROCOCCUS TETRADIUS; ARTICLE; BACTERIAL STRAIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLOSTRIDIUM; CLOSTRIDIUM COCHLEARIUM; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; EUBACTERIUM; EUBACTERIUM MULTIFORME; FUSOBACTERIUM NUCLEATUM; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; VIRUS REACTIVATION; VIRUS REPLICATION;

ACETYLATION; BACTERIA; BACTERIAL INFECTIONS; BASE SEQUENCE; BUTYRIC ACID; CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIGESTIVE SYSTEM; DNA, VIRAL; FEMALE; HISTONES; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MOUTH; MUCOUS MEMBRANE; VAGINA; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

ANAEROCOCCUS TETRADIUS; BACTERIA (MICROORGANISMS); CLOSTRIDIUM COCHLEARIUM; EUBACTERIUM MULTIFORME; FUSOBACTERIUM NUCLEATUM; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864343838     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-0936-2     Document Type: Article

References (50)

1. Colin L, Van Lint C (2009) Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6:111
2. Pace MJ, Agosto L, Graf EH, O'Doherty U (2011) HIV reservoirs and latency models. Virology 411:344-354
3. Marcello A (2006) Latency: the hidden HIV-1 challenge. Retrovirology 3:7
4. Bafica A, Scanga CA, Schito M, Chaussabel D, Sher A (2004) Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J Immunol 172:7229-7234 (Pubitemid 38747580)
5. Mbopi-Keou FX, Belec L, Teo CG, Scully C, Porter SR (2002) Synergism between HIV and other viruses in the mouth. Lancet Infect Dis 2:416-424 (Pubitemid 34693259)
6. Okamoto T, Akagi T, Shima H, Miwa M, Shimotohno K (1987) Superinduction of trans-activation accounts for augmented human immunodeficiency virus replication in HTLV-I-transformed cells. Jpn J Cancer Res 78:1297-1301 (Pubitemid 18038272)
7. Okamoto T, Matsuyama T, Mori S, Hamamoto Y, Kobayashi N et al (1989) Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res Hum Retroviruses 5:131-138 (Pubitemid 19116042)
8. Belyakov IM, Ahlers JD (2008) Functional CD8 + CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine. Trends Immunol 29:574-585
9. Brenchley JM, Douek DC (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1:23-30
10. Gupta K, Klasse PJ (2006) How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked? PLoS Med 3:e79
11. Kotler DP (2005) HIV infection and the gastrointestinal tract. AIDS 19:107-117 (Pubitemid 40409529)
12. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD (1989) Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J Exp Med 169:1137-1151 (Pubitemid 19085845)
13. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G et al (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12:1365-1371 (Pubitemid 44924494)
14. Haynes BF (2006) Gut microbes out of control in HIV infection. Nat Med 12:1351-1352 (Pubitemid 44924488)
15. Bernstein MS, Tong-Starksen SE, Locksley RM (1991) Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. J Clin Invest 88:540-545
16. Verani A, Scarlatti G, Comar M, Tresoldi E, Polo S et al (1997) C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 185:805-816 (Pubitemid 27119864)
17. Imai K, Ochiai K, Okamoto T (2009) Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol 182:3688-3695
18. Kurita-Ochiai T, Fukushima K, Ochiai K (1995) Volatile fatty acids, metabolic by-products of periodontopathic bacteria, inhibit lymphocyte proliferation and cytokine production. J Dent Res 74:1367-1373
19. Riggs MG, Whittaker RG, Neumann JR, Ingram VM (1977) n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268:462-464
20. Bisgrove D, Lewinski M, Bushman F, Verdin E (2005) Molecular mechanisms of HIV-1 proviral latency. Expert Rev Anti Infect Ther 3:805-814 (Pubitemid 41535402)
21. Macfarlane GT, Gibson GR (1995) Microbiological aspects of short chain fatty acid production in the large bowel. In: Cummings JH, Rombeau JL, Sakata T (eds) Physiological and clinical aspects of short-chain fatty acids. Cambridge University Press, Cambridge, pp 87-105
22. Murdoch DA (1998) Gram-positive anaerobic cocci. Clin Microbiol Rev 11:81-120 (Pubitemid 28046017)
23. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217:133-139 (Pubitemid 35441298)
24. Wilson MJ, Hall V, Brazier J, Lewis MA (2000) Evaluation of a phenotypic scheme for identification of the 'butyrate-producing' Peptostreptococcus species. J Med Microbiol 49:747-751 (Pubitemid 30623908)
25. Butera ST, Perez VL, Wu BY, Nabel GJ, Folks TM (1991) Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4 + cell model of chronic infection. J Virol 65:4645-4653
26. Folks TM, Clouse KA, Justement J, Rabson A, Duh E et al (1989) Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 86:2365-2368 (Pubitemid 19102509)
27. Imai K, Okamoto T (2006) Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem 281:12495-12505 (Pubitemid 43855336)
28. Imai K, Togami H, Okamoto T (2010) Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 285:16538-16545
29. Sheridan PL, Mayall TP, Verdin E, Jones KA (1997) Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev 11:3327-3340 (Pubitemid 28023957)
30. Verdin E, Paras P Jr, Van Lint C (1993) Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12:3249-3259 (Pubitemid 23232756)
31. Ando T, Kawabe T, Ohara H, Ducommun B, Itoh M et al (2001) Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J Biol Chem 276:42971-42977
32. Victoriano AF, Asamitsu K, Hibi Y, Imai K, Barzaga NG et al (2006) Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor. Antimicrob Agents Chemother 50:547-555 (Pubitemid 43190965)
33. Van Lint C, Emiliani S, Ott M, Verdin E (1996) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15:1112-1120 (Pubitemid 26077840)
34. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-375 (Pubitemid 19172974)
35. Sorensen BS, Sinding J, Andersen AH, Alsner J, Jensen PB et al (1992) Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events. J Mol Biol 228:778-786 (Pubitemid 23017269)
36. Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1-8
37. Coull JJ, Romerio F, Sun JM, Volker JL, Galvin KM et al (2000) The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 74:6790-6799 (Pubitemid 30470662)
38. Jiang G, Espeseth A, Hazuda DJ, Margolis DM (2007) c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 81:10914-10923 (Pubitemid 47536066)
39. Tyagi M, Karn J (2007) CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J 26:4985-4995 (Pubitemid 350261291)
40. Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E et al (2006) NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 25:139-149 (Pubitemid 43077303)
41. Golub EI, Li GR, Volsky DJ (1991) Induction of dormant HIV-1 by sodium butyrate: involvement of the TATA box in the activation of the HIV-1 promoter. AIDS 5:663-668
42. Brenchley JM, Price DA, Douek DC (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7:235-239
43. Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T (2009) Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci USA 106:18786-18791
44. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D et al (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350:546-550 (Pubitemid 27348430)
45. Spiegel CA, Amsel R, Eschenbach D, Schoenknecht F, Holmes KK (1980) Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 303:601-607 (Pubitemid 10053753)
46. Taha TE, Gray RH, Kumwenda NI, Hoover DR, Mtimavalye LA et al (1999) HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol 20:52-59 (Pubitemid 29045470)
47. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221-1227 (Pubitemid 17156038)
48. Mortensen PB, Clausen MR (1996) Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl 216:132-148 (Pubitemid 26129312)
49. Niederman R, Buyle-Bodin Y, Lu BY, Robinson P, Naleway C (1997) Short-chain carboxylic acid concentration in human gingival crevicular fluid. J Dent Res 76:575-579 (Pubitemid 127732637)
50. Stein TP, Koerner B, Schluter MD, Leskiw MJ, Gaprindachvilli T et al (1997) Weight loss, the gut and the inflammatory response in aids patients. Cytokine 9:143-147 (Pubitemid 27116890)